Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With … (NCT07043335) | Clinical Trial Compass
RecruitingNot Applicable
Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis
Turkey (Türkiye)50 participantsStarted 2025-07-01
Plain-language summary
The goal of this clinical trial is to investigate the efficacy of mesotherapy in patients with lateral epicondylitis and to determine whether it is as effective as extracorporeal shock wave therapy (ESWT).
Is mesotherapy an effective method in patients with lateral epicondylitis?
Researchers will compare Mesotherapy to extracorporeal shock wave therapy (ESWT) in patient with Lateral epicondylitis.
Patients will be randomly assigned to either the Mesotherapy group or the ESWT group using a closed envelope method.
* Group 1 (Mesotherapy group): Patients will receive a total of 5 sessions of mesotherapy, with one session every 7 days.
* Group 2 (ESWT group): Patients will receive a total of 5 sessions of Extracorporeal Shock Wave Therapy (ESWT), with one session every 7 days.
Patients will be assessed at three time points: before treatment, 30 minutes after the completion of the treatment, and 12 weeks after the completion of the treatment
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Aged between 18 and 65 years
* Pain and tenderness in the unilateral lateral epicondyle for ≥6 weeks
* Clinically diagnosed with Lateral Epicondylitis
* Patients without cognitive deficits who can follow verbal instructions Exclusion Criteria
* Receiving an interventional injection in the elbow region within the last 3 months
* Receiving physical therapy in the last 3 months
* Receiving regular nonsteroidal anti-inflammatory drug (NSAID) treatment in the last 2 weeks
* History of fracture or surgery in the affected elbow region
* Chronic inflammatory diseases
* Acute infection
* History of malignancy
* Coagulation disorders
* Pregnancy
* Presence of a pacemaker or electronic implants
* Cervical radiculopathy and entrapment neuropathy
* Drug allergies
* BMI \> 35
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
VAS
Timeframe: All measures were conducted at baseline, at the end of treatment (Week 5), at 12th weeks follow-up
2
Patient-Rated Tennis Elbow Evaluation
Timeframe: All measures were conducted at baseline, At the end of treatment (Week 5), at 12th weeks follow-ups
3
SF-12 Health Survey
Timeframe: All measures were conducted at baseline,At the end of treatment (Week 5) , 12th weeks follow-ups
Trial details
NCT IDNCT07043335
SponsorHaydarpasa Numune Training and Research Hospital